PREVENTION OF CARDIAC DISEASE BY SUBCUTANEOUS DEFEROXAMINE IN PATIENTS WITH THALASSEMIA MAJOR

被引：255
|
作者：
WOLFE, L
OLIVIERI, N
SALLAN, D
COLAN, S
ROSE, V
PROPPER, R
FREEDMAN, MH
NATHAN, DG
机构：
[1] CHILDRENS HOSP MED CTR, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA
[2] DANA FARBER CANC INST, BOSTON, MA USA
[3] HOSP SICK CHILDREN, DIV HEMATOL, TORONTO M5G 1X8, ONTARIO, CANADA
[4] HOSP SICK CHILDREN, DEPT CARDIOL, TORONTO M5G 1X8, ONTARIO, CANADA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1985年 / 312卷 / 25期
关键词：
D O I：
10.1056/NEJM198506203122503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1600 / 1603
页数：4
相关论文
共 50 条
  • [1] CARDIAC DISEASE FREE SURVIVAL IN PATIENTS WITH THALASSEMIA MAJOR TREATED WITH SUBCUTANEOUS DEFEROXAMINE - AN UPDATE OF THE TORONTO COHORT
    OLIVIERI, NF
    MCGEE, A
    LIU, P
    KOREN, G
    FREEDMAN, MH
    BENSON, L
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 612 : 585 - 586
  • [2] Cardiac disease-free survival in patients with Thalassemia major treated with subcutaneous deferoxamine. An update of the Toronto Cohort
    1600, Publ by New York Acad of Sciences, New York, NY, USA (612):
  • [3] PREVENTION OF HEART-DISEASE BY SUBCUTANEOUS DESFERRIOXAMINE IN PATIENTS WITH THALASSEMIA MAJOR
    RICHARDSON, ME
    MATTHEWS, RN
    ALISON, JF
    MENAHEM, S
    MITVALSKY, J
    BYRT, E
    HARPER, RW
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (06): : 656 - 661
  • [4] SUBCUTANEOUS INFUSION OF DEFEROXAMINE IN HOME THERAPY OF THALASSEMIA MAJOR
    GIROT, R
    THEVENIN, M
    BOUVERET, JP
    RYMER, JC
    JEANNEL, F
    PEDIATRIC RESEARCH, 1981, 15 (08) : 1213 - 1213
  • [5] COMBINED SUBCUTANEOUS INTRAVENOUS DEFEROXAMINE THERAPY FOR THALASSEMIA MAJOR
    HYMAN, CB
    ORTEGA, JA
    VARATTA, T
    CLINICAL RESEARCH, 1980, 28 (01): : A105 - A105
  • [6] THE EFFECT OF SUBCUTANEOUS DEFEROXAMINE ON THE CARDIAC PROFILE OF THALASSEMIA MAJOR - A 5-YEAR STUDY
    GIARDINA, PJV
    EHLERS, KH
    ENGLE, MA
    GRADY, RW
    HILGARTNER, MW
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 445 (JUN) : 282 - 292
  • [7] Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis
    Piga, A
    Gaglioti, C
    Fogliacco, E
    Tricta, F
    HAEMATOLOGICA, 2003, 88 (05) : 489 - 496
  • [8] Phlebotomy and bolus subcutaneous deferoxamine in Algerian patients with thalassemia major or intermedia or sickle cell disease treated with hydroxyurea
    Bradai, Mohamed
    Bachir, Dora
    De Montalembert, Mariane
    BLOOD, 2007, 110 (11) : 20B - 21B
  • [9] LONGITUDINAL GROWTH OF PATIENTS WITH THALASSEMIA MAJOR (HOMOZYGOUS BETA-THALASSEMIA) DURING CONTINUOUS SUBCUTANEOUS INFUSIONS OF DEFEROXAMINE
    KRUGER, N
    STUBBE, P
    TILLMANN, W
    SCHROTER, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (05) : 176 - 181
  • [10] DEFEROXAMINE IN THALASSEMIA MAJOR
    LUCARELLI, G
    CLIFT, R
    ANGELUCCI, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04): : 271 - 271
12345